Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maywufa CoTPE:1731 86 Days Inventory is 174.17 as of Dec. 2025, which is 2% below its 10-year median of 177.33. GuruFocus rates TPE:1731 with a GF Score™ of 86/100 and a GF Value™ of NT$26.87 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Maywufa Co ranks worse than 57.87% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Maywufa Co's Average Total Inventories for the
three
months ended in Dec. 2025 was NT$297 Mil. Maywufa Co's Cost of Goods Sold for the
three
months ended in Dec. 2025 was NT$156 Mil.
Hence, Maywufa Co's Days Inventory for the
three
months ended in Dec. 2025 was 174.17.
The historical rank and industry rank for Maywufa Co's Days Inventory or its related term are showing as below:
TPE:1731'
s Days Inventory Range Over the Past 10 Years
Min: 114.46 Med: 177.33 Max: 200.46
Current: 183.91
During the past 13 years, Maywufa Co's highest Days Inventory was 200.46. The lowest was 114.46. And the median was 177.33.
TPE:1731's Days Inventory is ranked worse than 57.87% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs TPE:1731: 183.91
Maywufa Co's Days Inventory
declined
from Dec. 2024 (186.21) to Dec. 2025 (174.17).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Maywufa Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maywufa Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.72.
Maywufa Co (TPE:1731) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Maywufa Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maywufa Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Maywufa Co Days Inventory Related Terms
Maywufa Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Maywufa Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maywufa Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maywufa Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maywufa Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Maywufa Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maywufa Co (TPE:1731) has a Days Inventory of 174.17 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maywufa Co and its competitors. This is near median its historical median of 177.33. Over the past decade, Maywufa Co's Days Inventory has ranged from 114.46 to 200.46. According to the industry distribution chart, Maywufa Co ranks #533 out of 921 companies in the Drug Manufacturers industry, placing it in the top 57.9%.
Is Maywufa Co's Days Inventory too high?
Maywufa Co's current Days Inventory of 174.17 is near median its 10-year median of 177.33. Over the past 10 years, this metric has ranged from a low of 114.46 to a high of 200.46. The Drug Manufacturers industry median Days Inventory is 164.48. Maywufa Co's value of 174.17 is 5.9% above this industry median. Based on the distribution chart, Maywufa Co ranks #533 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Maywufa Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maywufa Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Maywufa Co ranks #533 out of 921 companies for Days Inventory. This places Maywufa Co in the lower half of its industry. The industry median Days Inventory is 164.48. Maywufa Co's value of 174.17 is 5.9% above this benchmark. Historically, Maywufa Co's own Days Inventory has ranged from 114.46 to 200.46 over the past decade. While the company's 10-year median is 177.33 vs. the industry median of 164.48, Maywufa Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maywufa Co's current Days Inventory of 174.17 is 5.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maywufa Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maywufa Co's current Days Inventory is 174.17, which is near median its own 10-year median of 177.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maywufa Co stock overvalued right now?
Based on GuruFocus' analysis, Maywufa Co (TPE:1731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$26.87, compared to a current price of NT$20.55 — trading 23.5% below its estimated fair value. The current Days Inventory is 174.17, which is near median its 10-year median of 177.33 and 5.9% above the Drug Manufacturers industry median of 164.48. Maywufa Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Maywufa Co (TPE:1731), the current Days Inventory is 174.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maywufa Co (TPE:1731) Overvalued in 2026?
Based on GuruFocus' analysis, Maywufa Co stock appears to be undervalued.
The current stock price of NT$20.55 is trading 23.5% below its estimated GF Value™ of NT$26.87.
GuruFocus considers Maywufa Co to be Modestly Undervalued.
Key valuation signals for TPE:1731:
Days Inventory: 174.17 (near median its 10-year median of 177.33)
GF Value™: NT$26.87 vs. price of NT$20.55 (23.5% below fair value)
Industry Position: 5.9% above the Drug Manufacturers median (#533 of 921)
No single metric tells the full story. See the TPE:1731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maywufa Co Ltd operates as a drug manufacturer. The company is engaged in manufacturing of hair and skin care products. The company has two reportable segments segments: Management Department, Consumer Business Unit, and Pharmaceutical Business Unit. It derives maximum revenue from Pharmaceutical Business Unit.
86GF Score
Get the complete analysis for TPE:1731
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1731 has been successfully added to your 
